Team:Paris Bettencourt/Project/TMAU
From 2014.igem.org
BACKGROUND Trimethylamine (TMA) is a volatile compound smelling strongly of spoiled fish. It is produced by bacteria in the human gut and oxidized into a non-volatile compound in the liver by a flavin-containing monooxygenase 3 (FMO3). Trimethylaminuria (TMAU), or Fish Odor Syndrome, is a rare genetic disease caused by inactivating mutations in the FMO3 gene. Consequently, TMA accumulates in sweat, saliva, and urine, causing a strong fish odor. Patients suffer no other serious symptoms, except a difficult social condition. |
AIMS TMA is also processed by the trimethylamine monooxygenase (TMM) of Ruegeria pomeroyi, an enzyme similar to human FMO3. Expressing this enzyme in human skin bacteria should remove trimethylamine from sweat and reduce its unpleasant odor. TMM-expressing bacteria in a cream or spray could be a cheap and stable way to deliver the therapeutic enzyme to TMAU patients. |
RESULTS
|
Introduction | Results | Methods |
Figure 1. Trimethylamine production and degradation in the human body. (A) In humans, choline is converted into trimethylamine and acetaldehyde by the gut bacteria Desulfovibrio desulfuricans. (B) Trimethylamine is degraded in the liver into trimethylamine-N-oxyde by FMO3 (flavin-containing mono oxygenase 3). (C) Mutations in the FMO3 gene can cause the loss of the function of the enzyme. In these patients, trimethylamine is excreted into sweat, urine and breath, causing a strong fish odor.
Introduction
Trimethylamine (TMA) is a volatile compound produced in the intestine by Desulfovibrio desulfuricans by fermentation of choline (Craciun, S. et al., 2012) (Fig. 1A). In healthy patients, the FMO3 gene allows the degradation of TMA in the liver into a non-volatile compound, trimethylamine-N-oxide (Fig.1B). But a mutation in the FMO3 sequence is most of the time the cause of trimethylaminuria: TMA is not degraded and is then excreted in sweat, saliva and urine leading to a strong fish odor (Fig. 1C). This autosomal recessive disorder requires two nonfunctional alleles of the FMO3 gene. More than 40 known mutations can inactivate FMO3, and inactive alleles have an estimated 0.1-1% global frequency (Mitchell, S.C et al., 2001). The patients are otherwise healthy but the disease affect their social relationships and can lead to depression. There is currently no cure for this metabolic disorder. Some treatments, often focused on reducing the choline absorption from food, tend to lower the symptoms (RJ Mackay et al., 2011).
Figure 2. Odor panel of trimethylamine. 10 participants were asked to smell trimethylamine samples at different concentrations and asked whether they could detect any difference with a control (water). An odor threshold was found at 1 mM and trimethylamine at concentrations of 0.1 mM or below was not detected. Figure 3. Characterisation of TMM using indigo production. (A) TMM allows the degradation of trimethylamine into trimethylamine-N-oxide. (B) TMM activity can be detected by the presence of indigo, a blue dye. Indole is naturally produced from tryptophan by tryptophanase in E. coli and can be converted into indigo by TMM. (C) Indigo can be detected in TMM-expressing E.coli (left) but not in the control (right) after 14h of culture in LB medium supplemented with 2g/l of tryptophan. Figure 4. Average absorbances of DMSO extractions from bacterial lysates. This graph shows the absorbance spectra of DMSO extractions from TMM-expressing E. coli (+TMM) or control (-TMM) in LB medium (-trp) or in LB supplemented with tryptophan (+trp). The grey area shows the expected absorbance peak of indigo. Figure 5. GC/MS analysis of cultures of E. coli expressing TMM or an empty vector (control). (A) GC/MS spectra of triplicates of cultures of E. coli expressing TMM or an empty vector (control). The peaks were analysed and compared to a database, showing the confidence rate for TMA.RT = Retention timeMA = Measured Area (B) Average area of the peaks corresponding to TMA in TMM-expressing E.coli and control. p-value=0.0199 Figure 6. Diffusion model of trimethylamine through air. This animation shows the concentration of trimethylamine diffusing through air from a patient over a time period of 0 to 1000 hours. From the graph on the left of the animation, you can see that the odor threshold is reached very early in the model, given that the concentration of trimethylamine at the skin surface is kept at a constant concentration of 500-600 ppm.
Results
Odor panel of trimethylamine We first wanted to determine which concentration of trimethylamine we had to use for our experiments. Ten volonteers were asked to smell trimethylamine samples at different concentrations and to say whether they could detect any difference with a control (water). An odor threshold was found at 1 mM and trimethylamine at concentrations of 0.1 mM or below was not detected (Fig. 2). Cloning tmm was cloned into a Biobrick vector (pSB1C3) using XbaI and PstI restriction sites. We also cloned it into pSEVA315, an universal vector with a high-copy replication origin (Standard European Vector Architecture) using XbaI and HindIII restriction sites in order to express it into C. striatum. Both of the constructs were expressed in E. coli. Characterisation of TMM activity in E.coli The characterisation was performed on E.coli expressing tmm cloned into pSB1C3. TMM activity was found in TMM-expressing E. coli but not in empty vector-expressing E. coli. TMM does not only degrade trimethylamine into trimethylamine-N-oxide (Fig. 2A), but also converts indole into indigo (Fig. 2B). To measure the activity of TMM, the growth medium was supplemented with tryptophan, a precursor of indole, which is the substrate of TMM. After 14h of culture, cells were pelleted, washed twice with sterile water, resuspended in DMSO and sonicated (Fig. 2C). TMM activity was determined by measuring the absorbance spectra of the bacterial extractions. Peaks at 620 nm were found in TMM-expressing E.coli cultures supplemented with tryptophan, which was identified as indigo. Without tmm expression or without tryptophan, indigo production was minimal or absent (Fig. 3). Gas chromatography-mass spectrometry Gas chromatography-mass spectrometry (GC/MS) confirmed the activity of TMM by proving the degradation of trimethylamine(Fig. 4). It was performed on extractions from cultures of TMM-expressing E. coli (TMM) and control expressing an empty vector in a LB medium supplemented with trimethylamine (1 mM). The results show a significant decrease (p-value = 0,0199) of the concentration of TMA in TMM-expressing E.coli (Fig. 4B). This confirms the efficiency of degradation of the fish odor by TMM. Modeling of TMA diffusion A simple model was created for the diffusion of trimethylamine into the air using COMSOL Multiphysics (a physics-based interface to solve partial differential equations). The model is shown in Fig.6. From literature, it was found that the odor threshold of trimethylamine in air is approximately 3.2E-5 ppm air ( Nagata, 1993), using the triangle odor bag method. This odor threshold was reached approximately 10 hours in the model, at a distance of 5 cm from the skin surface.
Methods
Cloning The tmm gene was produced by gene synthesis (IDT). The final construct was codon-optimized for E. coli expresion and included a strong constitutive promoter and ribosome binding site. For E. coli expression, we cloned the Tmm construct into the standard high-copy BioBrick vector pSB1C3 using XbaI and PstI restriction sites. For expression in C. striatum we used the vector pSEVA351, an universal vector with a high-copy replication origin (Standard European Vector Architecture)using XbaI and HindIII restriction sites. Indigo absorbance TMM does not only degrade trimethylamine into trimethylamine-N-oxide, but also converts indole into indigo. Measurement of TMM activity was performed on TMM-expressing E.coli using the isolation of indigo protocol inspired of Choi H.S., Kim J.K et al. (2003). The control is E. coli expressing pSB1C3. Gas chromatography / Mass spectrometry For the GC-MS analysis, 1µl of the sample was injected into the instrument in split mode. A Rtx5MS- 30m column with 0.25-mm ID and 0.25µm df were used. The GC-MS run uses the following standardized parameters: - Injection temperature: 300°C - Interface temperature: 300°C - Ion Source: 250°C - Carrier Gas: Helium (flow rate of 1 ml min-1) The temperature program used was 3 min of isothermal heating at 50⁰C followed by heating at 350⁰C for 10 min. Mass spectra were recorded at 2 scan sec-1 with a scanning range of 40 to 850 m/z. X Caliber software is used to process and analyze the data from a GC-MS run. Quantify each component based on peak areas and normalization based on the internal standard. Modeling The model is based on a 2D axisymmetric geometry, with the air modeled as the space 5 cm around the skin surface. Here, the skin surface is kept at a constant concentration, C0 = 1.39 +/- 0.483 uM. This value refers to the approximate amount of trimethylamine in sweat (Bain, 2005). The diffusivity of trimethylamine through the air was calculated using the Chapman-Enskog theory of gas diffusivity given by the following equation: D = (1.858E-3 * T(3/2) * (1/M1 + 1/M2)(1/2)) / (p * s122 * w) where D is the diffusivity of the trimethylamine T is the room temperature, 298 K p is the air pressure, 1 atm M1 is the mass of the trimethylamine, 59.11 g/mol M2 is the mass of the air, 29 g/mol s12 is the average collision diameter, which is around 340 Angstroms for gas molecules in air, and w is the dimensionless temperature-dependent collision integral, usually on the order of 1. Thus, the diffusion coefficient of trimethylamine was tabulated to be 1.9E-9 m2/s.